Lily C. Tang, Stephen J. Tang: Neurochemistry in Clinical Application. Springer Science & Business Media, 2012, ISBN 978-1-4615-1857-0, S.48– (google.com).
doi.org
V. S. Tam, M. Myers, L. Cook: Dup 996 (3,3-bis(pyrindinylmethyl)-1-phenyl-2-one) enhances the stimulus-induced release of acetylcholine from rat brain in vitro and in vivo. In: Drug Development Research Band 19, Nummer 3, 1990, S. 285–300. doi:10.1002/ddr.430190307
C. Wu, K. Gopal, G. W. Gross, T. J. Lukas, E. J. Moore: An in vitro model for testing drugs to treat tinnitus. In: European journal of pharmacology. Band 667, Nummer 1–3, September 2011, S. 188–194, doi:10.1016/j.ejphar.2011.05.070, PMID 21718695.
W. M. Bryant, G. F. Huhn, J. H. Jensen, M. E. Pierce, C. Stammbach: A Large Scale Preparation of the Cognitive Enhancer Linopirdine. In: Synthetic Communications. Band 23, Nummer 11, 1993, S. 1617–1615, doi:10.1080/00397919308011258
nih.gov
ncbi.nlm.nih.gov
S. P. Aiken, R. Zaczek, B. S. Brown: Pharmacology of the neurotransmitter release enhancer linopirdine (DuP 996), and insights into its mechanism of action. In: Advances in pharmacology (San Diego, Calif.). Band 35, 1996, S. 349–384, PMID 8920211 (Review).
M. E. Schnee, B. S. Brown: Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons. In: The Journal of pharmacology and experimental therapeutics. Band 286, Nummer 2, August 1998, S. 709–717, PMID 9694925.
D. J. Fontana, G. T. Inouye, R. M. Johnson: Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission. In: Pharmacology, biochemistry, and behavior. Band 49, Nummer 4, Dezember 1994, S. 1075–1082, PMID 7886078.
G. W. Dent, B. L. Rule, S. W. Tam, E. B. De Souza: Effects of the memory enhancer linopirdine (Dup 996) on cerebral glucose metabolism in naive and hypoxia-exposed rats. In: Brain research. Band 620, Nummer 1, August 1993, S. 7–15, PMID 8402201.
G. W. Dent, B. L. Rule, Y. Zhan, R. Grzanna: The acetylcholine release enhancer linopirdine induces Fos in neocortex of aged rats. In: Neurobiology of aging. Band 22, Nummer 3, 2001 May-Jun, S. 485–494, PMID 11378256.
K. Rockwood, B. L. Beattie, M. R. Eastwood, H. Feldman, E. Mohr, W. Pryse-Phillips, S. Gauthier: A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease. In: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. Band 24, Nummer 2, Mai 1997, S. 140–145, PMID 9164692.
A. Börjesson, T. Karlsson, R. Adolfsson, M. Rönnlund, L. Nilsson: Linopirdine (DUP 996): cholinergic treatment of older adults using successive and non-successive tests. In: Neuropsychobiology. Band 40, Nummer 2, 1999, S. 78–85, PMID 10474062.
R. Zaczek, R. J. Chorvat, J. A. Saye, M. E. Pierdomenico, C. M. Maciag, A. R. Logue, B. N. Fisher, D. H. Rominger, R. A. Earl: Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. In: The Journal of pharmacology and experimental therapeutics. Band 285, Nummer 2, Mai 1998, S. 724–730, PMID 9580619.
C. Wu, K. Gopal, G. W. Gross, T. J. Lukas, E. J. Moore: An in vitro model for testing drugs to treat tinnitus. In: European journal of pharmacology. Band 667, Nummer 1–3, September 2011, S. 188–194, doi:10.1016/j.ejphar.2011.05.070, PMID 21718695.
